pros and cons to glp 1 What should you do when a patient doesn't respond a GLP-1? You've titrated the dose. You've optimized lifestyle support. They're adherent, motivated—and still, there is no expected weight loss. Before assuming GLP-1 receptor agonists | How

Brand-name medications and compounded formulations are not interchangeable when it comes to how long they last and how they should be stored

Emerging clinical literature has stirred interest in their relevance to many PMOS-related symptoms

Durability of triple combination therapy versus stepwise addition therapy in patients with new-onset T2DM: 3-year follow-up of EDICT

People with type 1 diabetes are at elevated risk for diabetic ketoacidosis, a dangerous condition where ketone levels rise uncontrollably alongside high blood glucose

Intermittent hypoxia appears to be a key mediator, with greater severity of obstructive sleep apnoea correlating with more pronounced spermatogenic impairment